Benzinga | Apr 30, 2021 08:02AM EDT

Alexion Pharmaceuticals Q1 Adj. EPS $3.52 Beats $3.16 Estimate, Sales $1.64B Beat $1.58B Estimate

Alexion Pharmaceuticals (NASDAQ:ALXN) reported quarterly earnings of $3.52 per share which beat the analyst consensus estimate of $3.16 by 11.39 percent. This is a 9.32 percent increase over earnings of $3.22 per share from the same period last year. The company reported quarterly sales of $1.64 billion which beat the analyst consensus estimate of $1.58 billion by 3.53 percent. This is a 13.20 percent increase over sales of $1.45 billion the same period last year.